HIV-associated primary CNS lymorbidity and utility of brain biopsy

Journal of the Neurological Sciences

Volumn 163, Issue 1, 1999, Pages 32-38

  Skolasky, R L ^a   Dal Pan, G J ^a   Olivi, A ^a   Lenz, F A ^a   Abrams, R A ^a   McArthur, J C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Brain biopsy; HIV infection; Morbidity (mortality); Primary CNS lymphoma

Indexed keywords

ARTICLE; BRAIN BIOPSY; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETROSPECTIVE STUDY; SAFETY; STEREOTAXIC SURGERY; SURVIVAL TIME; THROMBOCYTE COUNT; TOXOPLASMOSIS;

AIDS DEMENTIA COMPLEX; BRAIN; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; LYMPHOMA, AIDS-RELATED; MORBIDITY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033080772     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00315-3     Document Type: Article

References (33)

1. Evaluation and management of intracranial mass lesions in AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998;50:21-6.
2. Andrews B.T., Kenefiek T.P. Neurosurgical management of the acquired immunodeficiency syndrome: an update. West J Med. 158:1993;249-253.
3. Anson J.A., Click H.P., Reyes M. Diagnostic accuracy of AIDS-related CNS lesions. Surg Neurol. 37:1992;432-440.
4. Bacellar H., Munoz A., Miller E.N.et al. Temporal trend in the incidence of HIV-1 related neurologic disease: Multicenter AIDS Cohort Study 1982-1992. Neurology. 44:1994;1892-1900.
5. th Conference on Retroviruses and Opportunistic Infections. Washington D.C, 1997.
6. Baumgartner J.E., Rachlin J.R., Beckstead J.H.et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg. 73:1990;206-211.
7. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(Supplement):1-15.
8. Chang L., Miller B.L., McBride D.et al. Brain lesions in patients with AIDS: H-NMR spectroscopy. Radiology. 197:1995;525-531.
9. Chappell E.T., Guthrie B.L., Orenstein J. The role of stereotactic biopsy in the management of HIV-related focal brain lesions. Neurosurgery. 30:1992;825-829.
10. Circillo S.F., Rosenblum M.L. Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. Neurosurgery. 73:1990;720-724.
11. Cordero F., Lara C., Canas E.et al. Usefulness of cerebral biopsy in focal cerebral lesions in patients with human immunodeficiency virus infection. Med Clin (Barcelona). 107:1996;738-741.
12. Corn B.W., Donahue B.R., Rosenstock J.O. Palliation of AIDS-related primary lymphoma of the brain: observations from a multi-institutional database. International Journal of Radiation Oncology. Biol Phys. 38(3):1997;601-605.
13. Dal Pan G.J., McArthur J.C. Neuroepidemiology of HIV infection. Neuroepidemiology. 14(2):1996;359-382.
14. Davies M.A., Pell M.E., Brew B.K. Stereotactic biopsy of cerebral lesions in acquired immunodeficiency syndrome. J Clin Neurosci. 2:1995;40-44.
15. De Luca A., Antinori A., Cingolani A.et al. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in-vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol. 90:1995;844-849.
16. Eciden W., Bise K., Steude U.et al. The stereotactic biopsy diagnosis of focal intracerebral lesions in AIDS patients. Acta Neurol Scand. 87:1993;228-233.
17. Fitzgibbon G.M., Kafka H.P., Leach A.J.et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 28(3):1996;616-626.
18. Forsyth P.A., Yahalom J., DeAngelis L.M. Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology. 44(8):1994;1473-1479.
19. Gildenberg P.L., Langford L., Kim J.H.et al. Stereotactic biopsy in cerebral lesions of AIDS. Acta Neurochirurgia. 58(Suppl):1993;68-70.
20. Heald A.E., Hoffman J.M., Bartlett J.A., Waskin H.A. Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int J STD AIDS. 7:1996;337-346.
21. Holloway RG, Mushlin AI. Intracranial lesions in acquired immunodeficiency syndrome: Using decision analysis to determine the effectiveness of stereotactic brain biopsy. Neurology 1996:1010-5.
22. Iacoangeli M., Roselli R., Antinori A.et al. Experience with brain biopsy in acquired immunodeficiency syndrome related focal lesions of the central nervous system. Br J Surg. 81:1994;1508-1511.
23. Jacomet C., Girard P., Lebrette M.et al. Intravenous methotrexaic for primary central nervous system non-Hodgkin's lymphoma AIDS. AIDS. 11:1997;1725-1730.
24. Levy R.M., Russell B., Yungbluth M.et al. The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. Neurosurgery. 30:1992;186-190.
25. McArthur JC. Neurological diseases associated with human immunodeficiency virus type I infection. In: Johnson RT, Griffin JW. Current therapy in neurologic disease. St. Louis MO: Mosby, 1997.
26. Monforte A., Cinque P., Vago L.et al. A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol. 244(1):1997;35-39.
27. Moskowitz L.B., Hensley G.T., Chan J.C.et al. Brain biopsies in patients with acquired immunodeficiency syndrome. Arch Pathol Med. 108:1984;368-371.
28. Nielsen C.J., Gjerris F., Pedersen H.et al. Brain biopsy in AIDS. Diagnostic value and consequence. Acta Neurochirurgia. 127:1994;99-102.
29. Pierce M.A., Johnson M.D., Maciunas R.J.et al. Evaluating contrast enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med. 123:1993;594-598.
30. Steinmetz H., Arendt G., Hefter H.et al. Focal brain lesions in patients with AIDS: aetiologies and corresponding radiological patterns in a prospective study. J Neurol. 242:1995;69-74.
31. Wolk DA, Miseljic S, Civelek AC, Port BB, Chin RL, Skolasky RL, McArthur JC. Diagnostic utility of thallium-201 in HIV-associated mass lesions. Presented at the Fiftieth Annual Meeting of the American Academy of Neurology. Minneapolis, Minnesota, 1998.
32. Viswanathan R., Ironside J., Bell J.E.et al. Stereotactic brain biopsy in AIDS: does it contribute to patient management? Br J Neurosurg. 8:1994;307-311.
33. Zimmer C., Marzheuser S., Patt S.et al. Stereotactic brain biopsy in AIDS. J Neurol. 239:1992;394-400.